Dr. Scott H. Donaldson, MD

Dr. Donaldson practices at UNC Hospitals in Chapel Hill, North Carolina, part of University of North Carolina Health Care System.

Dr. Donaldson's NPI, 1225115785, was assigned on November 1, 2006. Dr. Donaldson graduated from University of Michigan Medical School in 1990. Dr. Donaldson holds North Carolina license 9300086.

Dr. Donaldson's primary practice is UNC Hospitals, at 101 Manning Drive, Chapel Hill, NC 27514 in Orange County. The practice phone is (919) 966-4141.

Dr. Donaldson's primary practice is UNC Hospitals in Chapel Hill, North Carolina, part of University of North Carolina Health Care System. Dr. Donaldson is also affiliated with UNC Health Rex. The medical group on file is UNC Faculty Physicians. Dmand AI also links Dr. Donaldson to 1 more therapy and rehab clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Donaldson practices, 3 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Donaldson's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Donaldson is licensed in North Carolina.

CMS data shows 192 Medicare services from Dr. Donaldson across 7 procedure codes in 2024, for 96 Medicare patients. Medicare paid $12,185 for them.

CMS counts 96 Medicare patients who saw Dr. Donaldson in 2024. The largest group is 65 to 74, with 30 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 26% are also on Medicaid. Their average risk score is 2.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Donaldson's median patient age at 68, with 53% women.

In 2024, Dr. Donaldson wrote 463 Medicare Part D claims for 21 patients. 43% of them were for generic drugs. CMS names the drug for 328 of them, across 13 drugs with 11 or more claims each, at $3,945,878 in total drug cost. In 2023, CMS named 274 claims across 10 drugs.

Dr. Donaldson accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Donaldson as offering telehealth.

Dmand AI links 73 papers to Dr. Donaldson, published from 2001 to 2024. 2022 was the busiest year, with 8. The most frequent topics are Cystic Fibrosis, Cystic Fibrosis Transmembrane Conductance Regulator and Aminophenols. Dr. Donaldson has published most often in J Cyst Fibros. Dr. Donaldson's most frequent co-authors are John P. Clancy, MD, Scott D. Sagel, MD and Joseph M. Pilewski.

Dmand AI links Dr. Donaldson to 3 clinical trials, 2 of them phase 1 studies. Conditions studied include Cystic Fibrosis and Infant, Newborn, Diseases. Open Payments lists research payments to Dr. Donaldson that name 1 trial.

CMS Open Payments shows 69 general payments to Dr. Donaldson from 14 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 86% of the total. Boehringer Ingelheim USA, Inc. paid the most, $35,989. It also lists 9 research payments totaling $14,374 from 2016 to 2021, naming 1 clinical trial.

Dr. Donaldson graduated from University of Michigan Medical School in 1990.